US EditionJohn FitzGerald: EU May Have to Fund Future Drug Development Amid Trump Moves
- On May 14, 2025, President Donald Trump signed an executive order in Bonita Springs, Fla., aiming to reduce U.S. Prescription drug prices using a 'most favored nation' pricing policy.
- This order builds on a 2021 initiative and intends to lower costs by 59% by requiring drugs under Medicare Part B be sold at the lowest prices paid by other developed nations.
- The order promotes transparency around Pharmacy Benefit Managers , encourages direct purchasing from manufacturers, and mandates federal notification of pricing within 30 days.
- Jeff Shea, President of BeneCard PBF, welcomed the order for focusing on patient well-being rather than profit, emphasizing that their role goes beyond managing pharmacy benefits to creating a system that supports the health and needs of American families ahead of investor gains.
- Trump's policy threatens Irish pharmaceutical exports worth about €50 billion to the U.S., risking jobs and suggesting the EU may need to fund future drug development amid potential U.S. Tariff and research funding changes.
15 Articles
15 Articles
Trump's Drug Price Policy: Impact & Market Reactions
Trump vs Big Pharma: The Price War That Could Cripple the Drug Industry Overview of Trump's Drug Pricing Policy In May 2025, President Donald Trump signed a sweeping executive order aimed at reducing prescription drug prices in the United States. The order introduces a "most-favored-nation" (MFN) pricing model, which seeks to align U.S. drug prices with those of countries where medications are sold at lower costs. This policy mandates that pharm…
South Korea’s Celltrion expects minimal impact from Trump's drug pricing order - tennews.in: National News Portal
Seoul, May 15 (IANS) Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely unaffected by US President Donald Trump’s executive order aimed at lowering drug prices to match those in other countries. The order seeks to address a drug pricing system in which the United States pays significantly more […] The post South Korea’s Celltrion expects minimal impact from Trump’s drug pricing order ap…
Latest Trump Executive Order Aims to Cut Prescription Drug Prices
Trump Signs Executive Order to Cut Drug Costs: What Employers Need to Know President Donald Trump has signed a new executive order that aims to reduce prescription drug costs through a “most favored nation” pricing policy. This order directs the U.S. government to pay no more for certain prescription drugs than other developed nations pay as their lowest price. Additionally, it instructs the Secretary of Health and Human Services to create a sys…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
